Regulation of STING activation by phosphoinositide and cholesterol
Article Meta
Article Date: 2025
Article URL: https://www.nature.com/articles/s41586-025-10076-0
Article Image: (not provided)
Summary
This paper examines how membrane lipids — specifically phosphoinositides and cholesterol — regulate the activation, localisation and signalling of STING, the central adaptor of cytosolic DNA sensing. The authors integrate structural and cell biological data (and place their findings in the context of recent work showing PI4P and other phosphoinositides interacting with STING, plus evidence that cholesterol and palmitoylation drive STING clustering at the trans-Golgi network). They describe mechanisms by which lipid interactions control STING trafficking from the endoplasmic reticulum to Golgi/TGN compartments, influence TBK1 recruitment and phosphorylation, and consequently modulate downstream type I interferon and inflammatory outputs.
Key Points
- STING activation is not only ligand-driven (by cGAMP) but also strongly influenced by its local lipid environment.
- Specific phosphoinositides (notably PI4P and related species) interact with STING and help direct its Golgi/TGN localisation and activation.
- Cholesterol-binding motifs and palmitoylation of STING promote clustering at the trans-Golgi network, which is important for phosphorylation by TBK1 and full signalling.
- Trafficking steps — ER retention, COPI/COPA-mediated retrograde transport and Golgi-to-endosome movement mediated by PI4KB/ARMH3 — are lipid-sensitive and determine signalling outcomes.
- Lipid-exchange processes (for example OSBP-driven sterol/PI4P exchange) provide a mechanistic link between cellular sterol flux and STING pathway engagement.
- Modulating cholesterol levels or interfering with lipid interactions can alter STING localisation and activity, with implications for antiviral responses, cancer biology and autoinflammatory disease.
- Recent complementary studies identify additional endogenous ligands (phosphoinositide species) and small molecules that target STING’s transmembrane pockets or act as molecular glues — highlighting therapeutic opportunities.
Context and relevance
STING is central to innate immune sensing of cytosolic DNA; its dysregulation is implicated in infection, cancer, ageing-related inflammation and autoinflammatory syndromes. This work places lipid regulation at the heart of STING control, linking membrane biochemistry (phosphoinositide composition, cholesterol content, palmitoylation) to how and where STING becomes activated. For researchers exploring antiviral mechanisms, cancer immunology or novel immunomodulatory drugs, these lipid-dependent control points are potential targets for modulation — either to boost antitumour/antiviral immunity or to dampen harmful inflammation.
Why should I read this
Short version: if you care about how STING decides to switch on or off, this is the paper. It shows that lipids aren’t just background scenery — they actively steer STING’s location and activity. So whether you’re hunting new drug targets, trying to understand immune-driven cancer behaviours, or tinkering with cholesterol-related effects on immunity, this saves you the time of digging through lots of scattered studies.
Author style
Punchy: this is an important, timely piece that amplifies STING’s regulation beyond protein–protein interactions to include membrane chemistry. If you’re working in innate immunity or immunotherapy, the mechanistic detail here is worth diving into — it points to concrete lipid-dependent levers you can target or measure.